Figure 8
From: Novel CMKLR1 Inhibitors for Application in Demyelinating Disease

Structures of α-NETA analogues with modified linker functional groups and chain length.
From: Novel CMKLR1 Inhibitors for Application in Demyelinating Disease

Structures of α-NETA analogues with modified linker functional groups and chain length.